Dr. Maida is the Chief Clinical Officer for Oncotelic, Inc. and its joint venture, SapuBioscience, LLC, focused on immunotherapy of cancer and infectious disease. He has over 30 years of experience in clinical research in oncology and has worked with many Center of Excellence and Key Opinion Leaders. He is responsible for overseeing the operations of the company and has experience in finance, operations, research, and commercial clinical and scientific development, regulatory, and manufacturing for various therapeutic modalities. Previously, he served as Vice President of Clinical Research and General Manager, Oncology, World-wide for PharmaNet, Inc., and President and CEO of Replicon NeuroTherapeutics. He raised or assisted in financings in excess of $200 million for start-up and emerging biotechnology companies and negotiated licensing agreements with various centers of excellence and premier pharmaceutical firms. Over the past 18 years, he has served in various executive roles, including Chairman, CEO, COO, CSO, CFO, and business development. He also served as Senior Financial Controller of Lockheed Missiles, a $1.7 billion division.
